Gambia 'advanced' in exploring legal action over toxic Indian cough
syrup
Send a link to a friend
[July 24, 2023]
By Pap Saine
BANJUL (Reuters) -Gambia's government is "far advanced" in exploring
avenues for potential legal action against Indian drugmaker Maiden
Pharmaceuticals and a local distributor over toxic cough syrups believed
to have killed dozens of children, it said on Friday.
At least 70 children in Gambia, most under 5 years old, died from acute
kidney injury last year. A government task force which investigated the
deaths found they were "a direct result" of contaminated cough and cold
syrups imported from India.
Gambia has fired the executive director and deputy director of its
Medicines Control Agency (MCA) and referred the matter to police after
the task force found that the medicines in question were not registered
with the MCA, which is required by law, the government said in a
statement.
The small West African country has hired a U.S. law firm to explore
legal action, the justice minister previously told Reuters.
The Indian drugmaker Maiden Pharmaceuticals has denied wrongdoing, and
the Indian government says that tests it conducted on the drugs showed
they were not contaminated. Atlantic Pharmaceuticals, a local
distributor of the drugs, could not be reached.
Families of 20 of the children have already sued the two companies as
well as Gambian authorities.
[to top of second column]
|
Ebrima Sagnia holds up a sign during a
news conference, calling for justice for the deaths of children
linked to contaminated cough syrups, in Serekunda, Gambia, November
4, 2022. REUTERS/Edward McAllister/File Photo
"The government is currently
benefiting from legal advice from a top tier international law
firm," Gambia's government said in the statement, adding it is also
pursuing potential redress through engagement with the Government of
India.
It also said that the health ministry has hired a firm that is
reviewing all the health-related legislation in the Gambia.
The World Health Organization said last year that the India-made
cough syrups contained lethal toxins ethylene glycol and diethylene
glycol – commonly used in car brake fluid and other products not fit
for human consumption.
"There is an urgent need for a quality control laboratory to conduct
proper testing on all medicines and related products imported into
the country," the Gambian statement said, adding that the World Bank
is helping the country build a laboratory.
(Reporting by Pap Saine in Banjul, Gambia; Writing by Nellie
PeytonEditing by Louise Heavens and Matthew Lewis)
[© 2023 Thomson Reuters. All rights
reserved.]This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |